{"id":1850,"date":"2024-06-27T08:52:51","date_gmt":"2024-06-27T15:52:51","guid":{"rendered":"https:\/\/blogschapman.wpenginepowered.com\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/"},"modified":"2024-06-27T08:52:51","modified_gmt":"2024-06-27T15:52:51","slug":"national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics","status":"publish","type":"post","link":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/","title":{"rendered":"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics"},"content":{"rendered":"<div class=\"flex flex-grow flex-col max-w-full\">\n<div class=\"min-h-[20px] text-message flex flex-col items-start whitespace-pre-wrap break-words [.text-message+&amp;]:mt-5 juice:w-full juice:items-end overflow-x-auto gap-2\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"143b5332-e3b1-4ef3-893b-b19c6f47b775\">\n<div class=\"flex w-full flex-col gap-1 juice:empty:hidden juice:first:pt-[3px]\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<p><a href=\"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-sumbria.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-1858 alignleft\" src=\"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-sumbria.jpg\" alt=\"\" width=\"235\" height=\"240\"><\/a>Dr. <a href=\"https:\/\/www.chapman.edu\/our-faculty\/rachita-sumbria\" target=\"_blank\" rel=\"noopener noreferrer\">Rachita Sumbria<\/a>, an associate professor at Chapman University&#8217;s <a href=\"https:\/\/www.chapman.edu\/pharmacy\/\">School of Pharmacy<\/a>, has been awarded an NIH R01 grant from the National Institute on Aging, receiving $1.71 million over the next 5 years for research on Alzheimer\u2019s disease (AD) therapeutics. This project is founded on data from her lab&#8217;s earlier successes in modifying erythropoietin (EPO) to cross the blood-brain barrier (BBB) with promising results in treating AD.<\/p>\n<p>EPO&#8217;s ability to modulate AD-related pathways and its neuroprotective effects provide the rationale for its development, although its limited BBB penetration and hematopoietic side effects pose challenges. The proposed solution involves fusing EPO with a monoclonal antibody (MAb) against the transferrin receptor (TfR) to facilitate BBB penetration and reduce side effects.<\/p>\n<p>The funds will be used to conduct dose-escalation and safety studies in various AD models, and to investigate the molecular pathways modulated by TfRMAb-EPO, building on prior NIH R21-funded proof-of-concept studies. Preliminary data indicate that this BBB-penetrating EPO has better therapeutic and hematologic indices than EPO alone. EPO\u2019s neuroprotective effects and ability to modulate AD-related pathways justify its development, despite challenges like limited BBB penetration and hematopoietic side effects. The findings may establish a clinically feasible method for sustainable EPO delivery to the AD brain.<\/p>\n<p><em>The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Rachita Sumbria, an associate professor at Chapman University&#8217;s School of Pharmacy, has been awarded an NIH R01 grant from [&hellip;]<\/p>\n","protected":false},"author":4726,"featured_media":1856,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"custom_author_name":"","chapman_pin_hero_slider":"","footnotes":""},"categories":[185,405,174,33,37,53],"tags":[1739,1740,1741,1742,1743,1744,1117,1745,1746,1747,1748,1749,1408,1750,1751,1752,1753,1754,1755,1756,1757,1758,1759,1760,1761,1762,1763,1764,861,1765,1766,1767,1768,1769,1665,1770,1771,1772,1773,1774,1775,1776,1777,1778,1779,1780,1781,1782,1783,1784,1785,1786],"class_list":["post-1850","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-awards","category-faculty","category-grants","category-pharmacy-industry","category-publications","category-research","tag-1-71-million","tag-5-years","tag-ad-mouse-models","tag-alzheimers-disease","tag-alzheimers-disease-therapeutics","tag-amyloidosis","tag-blood-brain-barrier","tag-blood-brain-barrier-bbb-penetrating-erythropoietin","tag-clinical-feasibility","tag-cognitive-function","tag-disease-modifying-treatment-for-ad","tag-dose-escalation-studies","tag-dr-rachita-sumbria","tag-drug-delivery-systems","tag-efficacy","tag-erythropoietin-epo","tag-facilitate-bbb-penetration","tag-fusing-epo","tag-hematologic-indices","tag-hematopoietic-side-effects","tag-limited-bbb-penetration","tag-lower-doses","tag-mechanistic-insights","tag-modulate-ad-related-pathways","tag-molecular-pathways","tag-monoclonal-antibody-mab","tag-mouse-models","tag-national-institute-on-aging","tag-national-institutes-of-health","tag-neuroprotective-effects","tag-nih-r01-grant","tag-pathological-brain-a42","tag-pi","tag-preclinical-development","tag-preliminary-data","tag-r21-funded-proof-of-concept-studies","tag-reduce-side-effects","tag-safety-profile","tag-safety-studies","tag-specific-aims","tag-sumbria-lab","tag-sustainable-epo-delivery","tag-synaptophysin","tag-tauopathy","tag-tfrmab-epo","tag-tfrmab-epo-fusion","tag-therapeutic-for-alzheimers-disease-ad","tag-therapeutic-indices","tag-therapeutic-range","tag-third-active-r01","tag-tolerable-doses","tag-transferrin-receptor-tfr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>School of Pharmacy | Chapman Blogs<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"Dr. Rachita Sumbria, an associate professor at Chapman University&#8217;s School of Pharmacy, has been awarded an NIH R01 grant from [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-27T15:52:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"780\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luke O&#039;Connell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luke O&#039;Connell\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/\"},\"author\":{\"name\":\"Luke O'Connell\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#\\\/schema\\\/person\\\/18d9b01a23542c5f77fb25bc247b33e0\"},\"headline\":\"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics\",\"datePublished\":\"2024-06-27T15:52:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/\"},\"wordCount\":245,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2024\\\/06\\\/rachita-scaled.jpg\",\"keywords\":[\"$1.71 million\",\"5 years\",\"AD mouse models\",\"Alzheimer\u2019s disease\",\"Alzheimer\u2019s disease therapeutics\",\"amyloidosis\",\"blood-brain barrier\",\"blood-brain barrier (BBB) penetrating erythropoietin\",\"clinical feasibility\",\"cognitive function\",\"disease-modifying treatment for AD\",\"dose-escalation studies\",\"Dr. Rachita Sumbria\",\"drug delivery systems\",\"efficacy\",\"Erythropoietin (EPO)\",\"facilitate BBB penetration\",\"fusing EPO\",\"hematologic indices\",\"hematopoietic side effects\",\"limited BBB penetration\",\"lower doses\",\"mechanistic insights\",\"modulate AD-related pathways\",\"molecular pathways\",\"monoclonal antibody (MAb)\",\"mouse models\",\"National Institute on Aging\",\"National Institutes of Health\",\"neuroprotective effects\",\"NIH R01 grant\",\"pathological brain A\u03b242\",\"PI\",\"preclinical development\",\"preliminary data\",\"R21-funded proof-of-concept studies\",\"reduce side effects\",\"safety profile\",\"safety studies\",\"specific aims\",\"Sumbria Lab\",\"sustainable EPO delivery\",\"synaptophysin\",\"tauopathy\",\"TfRMAb-EPO\",\"TfRMAb-EPO fusion\",\"therapeutic for Alzheimer\u2019s disease (AD)\",\"therapeutic indices\",\"therapeutic range\",\"third active R01\",\"tolerable doses\",\"transferrin receptor (TfR)\"],\"articleSection\":[\"Awards\",\"Faculty\",\"Grants\",\"Pharmacy Industry\",\"Publications\",\"Research\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/\",\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/\",\"name\":\"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2024\\\/06\\\/rachita-scaled.jpg\",\"datePublished\":\"2024-06-27T15:52:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2024\\\/06\\\/rachita-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2024\\\/06\\\/rachita-scaled.jpg\",\"width\":2560,\"height\":780},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/2024\\\/06\\\/27\\\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#website\",\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/\",\"name\":\"School of Pharmacy\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#organization\",\"name\":\"School of Pharmacy\",\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2026\\\/03\\\/MasterBrand_000-scaled-1.png\",\"contentUrl\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/wp-content\\\/uploads\\\/sites\\\/65\\\/2026\\\/03\\\/MasterBrand_000-scaled-1.png\",\"width\":2560,\"height\":435,\"caption\":\"School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/#\\\/schema\\\/person\\\/18d9b01a23542c5f77fb25bc247b33e0\",\"name\":\"Luke O'Connell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g\",\"caption\":\"Luke O'Connell\"},\"url\":\"https:\\\/\\\/blogs.chapman.edu\\\/pharmacy\\\/author\\\/oaconnellchapman-edu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"School of Pharmacy | Chapman Blogs","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/","og_locale":"en_US","og_type":"article","og_title":"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics - School of Pharmacy","og_description":"Dr. Rachita Sumbria, an associate professor at Chapman University&#8217;s School of Pharmacy, has been awarded an NIH R01 grant from [&hellip;]","og_url":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/","og_site_name":"School of Pharmacy","article_published_time":"2024-06-27T15:52:51+00:00","og_image":[{"width":2560,"height":780,"url":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg","type":"image\/jpeg"}],"author":"Luke O'Connell","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luke O'Connell","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#article","isPartOf":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/"},"author":{"name":"Luke O'Connell","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#\/schema\/person\/18d9b01a23542c5f77fb25bc247b33e0"},"headline":"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics","datePublished":"2024-06-27T15:52:51+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/"},"wordCount":245,"publisher":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#organization"},"image":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg","keywords":["$1.71 million","5 years","AD mouse models","Alzheimer\u2019s disease","Alzheimer\u2019s disease therapeutics","amyloidosis","blood-brain barrier","blood-brain barrier (BBB) penetrating erythropoietin","clinical feasibility","cognitive function","disease-modifying treatment for AD","dose-escalation studies","Dr. Rachita Sumbria","drug delivery systems","efficacy","Erythropoietin (EPO)","facilitate BBB penetration","fusing EPO","hematologic indices","hematopoietic side effects","limited BBB penetration","lower doses","mechanistic insights","modulate AD-related pathways","molecular pathways","monoclonal antibody (MAb)","mouse models","National Institute on Aging","National Institutes of Health","neuroprotective effects","NIH R01 grant","pathological brain A\u03b242","PI","preclinical development","preliminary data","R21-funded proof-of-concept studies","reduce side effects","safety profile","safety studies","specific aims","Sumbria Lab","sustainable EPO delivery","synaptophysin","tauopathy","TfRMAb-EPO","TfRMAb-EPO fusion","therapeutic for Alzheimer\u2019s disease (AD)","therapeutic indices","therapeutic range","third active R01","tolerable doses","transferrin receptor (TfR)"],"articleSection":["Awards","Faculty","Grants","Pharmacy Industry","Publications","Research"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/","url":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/","name":"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics - School of Pharmacy","isPartOf":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#primaryimage"},"image":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg","datePublished":"2024-06-27T15:52:51+00:00","breadcrumb":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#primaryimage","url":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg","contentUrl":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2024\/06\/rachita-scaled.jpg","width":2560,"height":780},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/2024\/06\/27\/national-institute-on-aging-awards-grant-to-dr-rachita-sumbria-for-alzheimers-disease-theraputics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.chapman.edu\/pharmacy\/"},{"@type":"ListItem","position":2,"name":"National Institute on Aging Awards Grant to Dr. Rachita Sumbria for Alzheimer&#039;s Disease Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#website","url":"https:\/\/blogs.chapman.edu\/pharmacy\/","name":"School of Pharmacy","description":"","publisher":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.chapman.edu\/pharmacy\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#organization","name":"School of Pharmacy","url":"https:\/\/blogs.chapman.edu\/pharmacy\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2026\/03\/MasterBrand_000-scaled-1.png","contentUrl":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-content\/uploads\/sites\/65\/2026\/03\/MasterBrand_000-scaled-1.png","width":2560,"height":435,"caption":"School of Pharmacy"},"image":{"@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.chapman.edu\/pharmacy\/#\/schema\/person\/18d9b01a23542c5f77fb25bc247b33e0","name":"Luke O'Connell","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c74902d57c73ea06032ba7d71ab8e9ba92dfee6aa00579ce8b19341b060b28f2?s=96&d=mm&r=g","caption":"Luke O'Connell"},"url":"https:\/\/blogs.chapman.edu\/pharmacy\/author\/oaconnellchapman-edu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/posts\/1850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/users\/4726"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/comments?post=1850"}],"version-history":[{"count":0,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/posts\/1850\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/media\/1856"}],"wp:attachment":[{"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/media?parent=1850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/categories?post=1850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.chapman.edu\/pharmacy\/wp-json\/wp\/v2\/tags?post=1850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}